Enanta Pharmaceuticals
ENTA
#7670
Rank
C$0.49 B
Marketcap
C$16.92
Share price
-2.64%
Change (1 day)
101.81%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2025 (TTM): -C$0.11 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are C$65.32 Million. In 2024 the company made an earning of -C$0.14 Billion, an increase over its 2023 earnings that were of -C$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.11 Billion-20.58%
2024 -C$0.14 Billion-23.87%
2023 -C$0.18 Billion4.39%
2022 -C$0.17 Billion-4.4%
2021 -C$0.18 Billion91.12%
2020 -C$92.82 Million-407.13%
2019 C$30.21 M-78.63%
2018 C$0.14 B117.97%
2017 C$64.88 M-574.65%
2016 -C$13.67 Million-110.83%
2015 C$0.12 B-4.5%
2014 C$0.13 B-638.53%
2013 -C$24.55 Million-137.98%
2012 C$64.62 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$46.61 B-44,324.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.71 B-21,653.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
C$9.16 B-8,795.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$6.46 B-6,237.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$31.15 B-29,655.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$12.95 B-12,395.04%๐Ÿ‡บ๐Ÿ‡ธ USA